From Juliana Taiwo-Obalonye, Abuja The Renewed Hope Initiative, led by Nigeria’s First Lady, Senator Oluremi Tinubu, has disbursed one million naira each to 47 tertiary students across Nigeria, totalling N47 million, along with laptops to aid their studies. The beneficiaries include students at various academic levels: 5 in 400 level, 39 in 300 level, 2…

Successful clinical trials of a cancer vaccine — using mRNA technology — by Russian researchers have created hope among the scientific community

Longevity investing is shifting. As VCs stumble, sovereign wealth funds, family dynasties, and billionaires are seizing control of the science of aging.

Russia’s mRNA-based Enteromix vaccine shows complete efficacy and safety in early trials, heralding a new era in cancer treatment.

Once synonymous with failing infrastructure and interrupted care, the Lagos University Teaching Hospital (LUTH), Idi-Araba, is now undergoing a striking rebirth. Backed by unprecedented federal funding, sweeping renovations and new The post Inside LUTH’s infrastructure renaissance appeared first on The Nation Newspaper.

New Delhi: Russia’s experimental mRNA-based cancer vaccine Enteromix has demonstrated 100% efficacy and safety in clinical trials, raising hopes for a breakthrough in the global fight against cancer. Developed using similar technology as COVID-19 vaccines, Enteromix works by training the immune system to recognize and eliminate cancer cells without serious side effects.The announcement was made…

Researchers reportedly observed reductions in tumor size and slowed tumor progression—in the range from 60 to 80 percent.

CMS will soon open applications for its $50 billion Rural Health Transformation Program. Many so-called “rural” hospitals are actually located in urban areas.

A team of Hong Kong scientists is developing an injectable treatment that could potentially improve blood flow in diabetes patients’ feet, in the hopes that it will reduce the need for amputation by rebuilding tissue in the arteries. They also hope to apply the treatment to peripheral artery disease or PAD, a condition caused by…

The overall survival OS hazard ratio HR in the HARMONi trial was 0 78 with a nominal p-value of 0 0332 In the North American patients the OS HR was 0 70 The HARMONi trial has already demonstrat …